Cargando…
“Pill-in-the-Pocket” Treatment of Propafenone Unmasks ECG Brugada Pattern in an Atrial Fibrillation Patient With a Common SCN5A R1193Q Polymorphism
Background: “Pill-in-the-pocket” (PIP) treatment with type IC drugs for cardioversion of recent-onset atrial fibrillation (AF) has been recommended in guidelines. Major adverse effects have been often reported, and the underlying mechanisms are proposed to be associated with the genetic backgrounds....
Autores principales: | Li, Linling, Ruan, Yanfei, Liu, Nian, Zhao, Qianqian, Zhang, Mengxia, Li, Xin, Zuo, Song, Le, Jiang, Wu, Kui, Bai, Rong, Ma, Changsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450223/ https://www.ncbi.nlm.nih.gov/pubmed/30984031 http://dx.doi.org/10.3389/fphys.2019.00353 |
Ejemplares similares
-
Reassessing the Safety of Pill-in-the-Pocket Propafenone
por: Kim, Andrew G, et al.
Publicado: (2023) -
Deep learning unmasks the ECG signature of Brugada syndrome
por: Melo, Luke, et al.
Publicado: (2023) -
Propafenone Overdose: From Cardiogenic Shock to Brugada
Pattern
por: Gil, Julio, et al.
Publicado: (2018) -
Flecainide challenge test: Predictors of unmasking of type 1 Brugada ECG pattern among those with non-type 1 Brugada ECG pattern
por: Prasad, Srinivasa, et al.
Publicado: (2016) -
Brugada-Phenocopy Induced by Propafenone Overdose and Successful Treatment: A Case Report
por: Arı, Mehmet Emre, et al.
Publicado: (2017)